S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold

LAVA Therapeutics (LVTX) Institutional Ownership

$2.71
-0.12 (-4.24%)
(As of 04/19/2024 ET)

Institutional Ownership Changes (13F Filings) for LAVA Therapeutics (NASDAQ:LVTX)

Number of
Institutional Buyers
(last 12 months)
5
Total
Institutional Inflows
(last 12 months)
$1.11M
Number of
Institutional Sellers
(last 12 months)
1
Total
Institutional Outflows
(last 12 months)
$824.45K
Get LVTX Insider Trade Alerts

Want to know when executives and insiders are buying or selling LAVA Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Skip Chart & View Institutional Buying and Selling Data

LVTX Institutional Buying and Selling by Quarter

LAVA Therapeutics Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
4/10/2024 Pathway Financial Advisors LLC14,000$47K0.0%N/A0.000%
2/15/2024Novo Holdings A S1,878,194$2.97M0.2%-21.7%7.409%
2/15/2024Citadel Advisors LLC21,552$34K0.0%N/A0.085%
8/11/2023PNC Financial Services Group Inc.65,000$132K0.0%+30.0%0.000%
5/12/2023Bruce & Co. Inc.671,874$1.12M0.3%+571.9%2.650%
5/12/2023Bank of America Corp DE32,240$54K0.0%+20,566.7%0.127%
2/15/2023Bruce & Co. Inc.100,000$350K0.1%N/A0.394%
2/15/2023Silverarc Capital Management LLC437,762$1.53M0.4%-28.3%1.727%
2/13/2023Renaissance Technologies LLC18,800$66K0.0%N/A0.074%
2/10/2023PNC Financial Services Group Inc.50,000$175K0.0%N/A0.197%
2/1/2023Bank of Montreal Can89,600$530K0.0%N/A0.353%
11/14/2022UBS Oconnor LLC75,000$343K0.0%N/A0.296%
10/28/2022Silverarc Capital Management LLC610,809$2.79M0.9%N/A2.409%
8/16/2022DAFNA Capital Management LLC128,335$379K0.1%-7.9%0.506%
8/15/2022Nantahala Capital Management LLC322,980$953K0.0%-3.3%1.274%
8/15/2022Point72 Asset Management L.P.111,993$330K0.0%-4.3%0.442%
8/15/2022Millennium Management LLC96,405$276K0.0%-36.0%0.380%
5/13/2022Nantahala Capital Management LLC334,164$1.47M0.1%-7.4%1.318%
2/14/2022Point72 Asset Management L.P.119,152$655K0.0%-3.8%0.470%
11/15/2021Point72 Asset Management L.P.123,911$734K0.0%N/A0.489%
11/15/2021AXA S.A.229,121$1.36M0.0%+3.8%0.904%
11/12/2021Falcon Edge Capital LP140,229$830K0.1%-3.2%0.553%
8/17/2021Woodline Partners LP86,904$946K0.0%-23.3%0.343%
8/17/2021Millennium Management LLC138,831$1.51M0.0%-38.6%0.548%
8/16/2021Redmile Group LLC2,816,196$30.64M0.5%-0.3%11.108%
8/13/2021Geode Capital Management LLC12,997$141K0.0%N/A0.051%
8/11/2021Bank of New York Mellon Corp25,288$275K0.0%-26.3%0.100%
8/10/2021Nicholas Investment Partners LP781,867$8.51M0.5%-4.0%3.084%
8/2/2021New York State Common Retirement Fund19,136$208K0.0%-26.3%0.075%
5/27/2021Davidson Kempner Capital Management LP2,000$30K0.0%N/A0.008%
5/18/2021Millennium Management LLC226,205$3.44M0.0%N/A0.892%
5/18/2021Point72 Asset Management L.P.5,561$84K0.0%N/A0.022%
5/18/2021Tudor Investment Corp Et Al19,614$298K0.0%N/A0.077%
5/18/2021Redmile Group LLC2,824,409$42.90M0.6%N/A11.141%
5/18/2021Davidson Kempner Capital Management LP2,000$30K0.0%N/A0.008%
5/18/2021Citadel Advisors LLC60,442$918K0.0%N/A0.238%
5/18/2021Falcon Edge Capital LP150,454$2.29M0.1%N/A0.593%
5/17/2021Point72 Hong Kong Ltd9,355$142K0.0%N/A0.037%
5/17/2021Woodline Partners LP113,242$1.72M0.0%N/A0.447%
5/17/2021Caas Capital Management LP30,000$456K0.0%N/A0.118%
Tiny Biotech Stock Wins $75 Billion Patent (Ad)

A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.

Find out more here >>>
5/17/2021Pinz Capital Management LP25,900$393K0.1%N/A0.102%
5/17/2021Sphera Funds Management LTD.213,894$3.25M0.2%N/A0.844%
5/17/2021Novo Holdings A S3,327,312$50.54M2.1%N/A13.124%
5/14/2021Nantahala Capital Management LLC381,227$5.79M0.2%N/A1.504%
5/14/2021Nicholas Investment Partners LP814,840$12.38M0.9%N/A3.214%
5/14/2021Monashee Investment Management LLC265,000$3.02M0.5%N/A1.045%
5/13/2021Bank of New York Mellon Corp34,319$521K0.0%N/A0.135%
5/12/2021Pura Vida Investments LLC54,000$820K0.0%N/A0.213%
(Data available from 1/1/2016 forward)

LVTX Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of LVTX shares?

During the previous two years, 14 institutional investors and hedge funds held shares of LAVA Therapeutics. The most heavily invested institutionals were Novo Holdings A S ($2.97M), Silverarc Capital Management LLC ($1.53M), Bruce & Co. Inc. ($1.12M), Nantahala Capital Management LLC ($953K), Bank of Montreal Can ($530K), DAFNA Capital Management LLC ($379K), and UBS Oconnor LLC ($343K).Learn more on LVTX's institutional investors.

Which institutional investors have been buying LAVA Therapeutics stock?

Of the 9 institutional investors that purchased LAVA Therapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Bruce & Co. Inc. ($671.87K), Silverarc Capital Management LLC ($610.81K), Bank of Montreal Can ($89.60K), UBS Oconnor LLC ($75K), PNC Financial Services Group Inc. ($65K), Bank of America Corp DE ($32.08K), and Citadel Advisors LLC ($21.55K).

How much institutional buying is happening at LAVA Therapeutics?

Institutional investors have bought a total of 1,598,719 shares in the last 24 months. This purchase volume represents approximately $5.15M in transactions.

Which LAVA Therapeutics major shareholders have been selling company stock?

The following institutional investors have sold LAVA Therapeutics stock in the last 24 months: Novo Holdings A S ($521.81K), Silverarc Capital Management LLC ($173.05K), Millennium Management LLC ($54.23K), Nantahala Capital Management LLC ($37.83K), DAFNA Capital Management LLC ($11.00K), and Point72 Asset Management L.P. ($4.99K).

How much institutional selling is happening at LAVA Therapeutics?

Institutional investors have sold a total of 802,891 shares in the last 24 months. This volume of shares sold represents approximately $1.79M in transactions.


This page (NASDAQ:LVTX) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners